116905 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Serine endopeptidases (3.4.21) Matriptase (3.4.21.109)
SIRNA OR SALT THEREOF AND MEDICAMENT FOR INHIBITING EXPRESSION OF TMPRSS6 GENE, AND USE THEREOF
#2TRANSMEMBRANE PROTEASE, SERINE 6 (TMPRSS6) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#3NOVEL IL-15 PRODRUGS AND METHODS OF USE THEREOF
#4COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION
#5Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#6VERTEBRATE CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A POLYPEPTIDE OF INTEREST
#7Transmembrane protease, serine 6 (TMPRSS6) iRNA compositions and methods of use thereof
#8COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION
#9Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#10Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#11IL-15 prodrugs and methods of use thereof
#12Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#13Methods and compositions for diagnosing and treating diseases
#14COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION
#15Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#16Prodruggable antibodies, prodrugs thereof, and methods of use and making
#17Compounds and methods for modulating TMPRSS6 expression
#18Vertebrate cells and methods for recombinantly expressing a polypeptide of interest
#19Modified MT-SP1 proteases that inhibit complement activation
#20Protease screening methods and proteases identified thereby
#21Protease screening methods and proteases identified thereby
#22PROTEASE SCREENING METHODS AND PROTEASES IDENTIFIED THEREBY
#23Modified proteases that inhibit complement activation
#24Methods and compositions for diagnosing and treating diseases
#25NOVEL DIAGNOSTIC MARKERS, ESPECIALLY FOR IN VIVO IMAGING, AND ASSAYS AND METHODS OF USE THEREOF
#26Diagnostic markers, especially for in vivo imaging and assays and methods of use thereof
#27Protease screening methods and proteases identified thereby
#28Modified proteases that inhibit complement activation
#29Diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
#30Cleavage of VEGF and VEGF receptor by wild-type and mutant proteases
#31Mutant MT-SP1 proteases with altered substrate specificity or activity